Doxepin Hydrochloride Capsule
Product Images NDC 64980-596

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Doxepin Hydrochloride (NDC 64980-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxepin-struct (Doxepin Struct)

Chemical structure of doxepin hydrochloride showing the tricyclic ring system with a methylated nitrogen and a hydrochloride component.*

FDA Label Image

Rising-logo (Rising Logo)

FDA Label Image

Doxepin-fig (Doxepin Fig)

This image contains a section of drug safety information listing potential serious side effects associated with Doxepin hydrochloride capsules. It includes symptoms such as suicidal thoughts, worsening depression or anxiety, agitation, insomnia, irritability, aggressive behavior, mania, and visual problems like eye pain and changes in vision. The text advises patients about risks and possible need for preventative eye exams.*

FDA Label Image

Doxepin-label1 (Doxepin Label1)

Label for Doxepin Hydrochloride Capsules, USP 10 mg by Rising Pharmaceuticals. The label indicates the product is an oral capsule form, with 100 capsules per container. It includes storage instructions, manufacturer information (Unique Pharmaceutical Laboratories, Mumbai, India), and distributor details (Rising Pharma Holdings, Inc., East Brunswick, NJ). The label also notes the product is Rx only and provides a pharmacist dispensing advisory.*

FDA Label Image

Doxepin-label2 (Doxepin Label2)

Label for Doxepin Hydrochloride Capsules, USP 25 mg, a prescription oral capsule medication by Rising Pharma Holdings, Inc. The package contains 100 capsules. It includes storage instructions, pharmacist dispensing instructions, and manufacturer details from Unique Pharmaceutical Laboratories, Mumbai, India.*

FDA Label Image

Doxepin-label3 (Doxepin Label3)

Packaging label for Doxepin Hydrochloride Capsules, USP 50 mg by Rising Pharmaceuticals. The label indicates this is a prescription oral capsule product, with a package count of 100 capsules. It includes directions to dispense the medication guide and storage instructions, along with manufacturer and distributor details.*

FDA Label Image

Doxepin-label4 (Doxepin Label4)

Label for Doxepin Hydrochloride Capsules, USP 75 mg, oral capsules. The package contains 100 capsules and is distributed by Rising Pharma Holdings, Inc. The label includes storage instructions, manufacturer details (Unique Pharmaceutical Laboratories, India), and a note to dispense the accompanying Medication Guide to each patient. The product is prescription-only and the lot was issued in 10/2023.*

FDA Label Image

Doxepin-label5 (Doxepin Label5)

Doxepin Hydrochloride Capsules, USP 100 mg by Rising Pharmaceuticals. The label indicates 100 capsules in the package, intended for oral use. It includes storage instructions, dosage and use guidance to refer to prescribing information, and notes it is Rx only. Manufactured by Unique Pharmaceutical Laboratories in India and distributed by Rising Pharma Holdings, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.